The Oncology Institute, Inc., a U.S.-based oncology company, reported earnings yesterday and saw a significant price gap with heavy trading volume. If the stock holds above $3 and shows follow-through tomorrow, it could be considered a buy
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.